EvolutionaryScale, a frontier AI research lab for biology, launched with ESM3, a milestone AI model capable of generating novel proteins. ESM3 generated a new Green Fluorescent Protein (GFP), a process that would take 500 million years of evolution to occur naturally. This milestone generative AI model allows interactive prompting...
Formation Bio, a tech-driven and AI-native pharma company, announced that it has raised $372MM of Series D financing. The financing was led by a16z with significant participation from Sanofi. Current investors also joined the round, including Sequoia, Thrive, Emerson Collective, and Lachy Groom, along with new investors, such as...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced a new collaboration with United Therapeutics (UT), a leading biotechnology company focused on providing a brighter future for patients through the development of novel pharmaceuticals and technologies. As part of this collaboration, Tempus will develop and investigate...
BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, announced a strategic collaboration with Genomic Testing Cooperative (GTC), a leading provider of molecular diagnostics for solid tumors and hematologic malignancies. This collaboration leverages the AI capabilities of both companies to deliver...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for systemic lupus erythematosus (SLE) to its discovery portfolio through its collaboration with BenevolentAI.
Second target to be selected this year from the extended collaboration with AstraZeneca, highlighting continued...
Life Sciences BC (LSBC) is pleased to announce the recipients of the 26th Annual Life Sciences BC Awards presented by Farris. These awards recognize the exceptional achievements of individuals, companies, and organizations across British Columbia’s life sciences sector that have successfully advanced health innovations and significantly enriched our dynamic...
Superbio AI, Inc., announced that it has entered into an initiative with Memorial Sloan Kettering Cancer Center (MSK) to make user-friendly biomedical AI available for providers, researchers, and drug developers working to advance the standard of care.
Under this initative, Superbio AI’s proprietary software platform will be utilized to deploy...
Rower Consulting, a trailblazer in cutting-edge analytics and artificial intelligence (AI) solutions, is pleased to announce a dynamic partnership with Dataiku, a pioneering force in Everyday AI. This collaboration marks a leap forward in Rower Consulting's mission to empower the pharmaceutical and other verticals with enhanced real-time analytics and strategic...
Scientist.com, the world's leading marketplace for biopharmaceutical research, announced the launch of a new Large Language Model (LLM)-powered research assistant called Elisa, named in reference to a widely used research test and ELIZA, a chatbot of the early 1960s. Elisa is the latest addition to a suite of proprietary...
Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated laboratory networks in the United States, and Ibex Medical Analytics, the leader in artificial intelligence (AI)-powered cancer diagnostics, announced the launch of the Ibex’s AI platform in routine practice within Alverno’s laboratory network in...
